![]() |
市場調查報告書
商品編碼
2059049
抗發炎膳食產品市場預測至2034年-按產品類型、功能成分、膳食定位、消費情境和最終使用者分類的全球分析Anti-Inflammatory Diet Products Market Forecasts to 2034 - Global Analysis By Product Type, Functional Ingredient, Dietary Positioning, Consumption Occasion, and End User |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球抗發炎飲食產品市場規模將達到 116 億美元,並在預測期內以 10% 的複合年成長率成長,到 2034 年將達到 248 億美元。
抗發炎膳食產品是指含有已知有助於減輕慢性發炎和維持整體健康的成分的食品和飲料。這些產品通常包含omega-3脂肪酸、薑黃、生薑、漿果、綠茶萃取物、抗氧化劑以及被認為具有抗發炎特性的植物來源營養素。它們的目標客戶通常是那些追求關節健康、心血管健康、免疫功能和健康老齡化的人。產品形式包括膳食補充品、飲料、點心、代餐食品和強化食品。人們對發炎與慢性疾病之間關聯的認知不斷提高,正在推動全球對以營養為重點的預防性保健產品的需求成長。
慢性病盛行率上升
消費者越來越意識到發炎在關節炎、心血管疾病和糖尿病等疾病中的作用。預防醫學的趨勢正在推動抗發炎食品和補充劑的消費。醫療保健專業人員推薦透過飲食療法來減輕發炎。食品公司正在開發使用功能性成分的產品以滿足此需求。有關抗炎食品的知識正透過社交媒體和健康宣傳宣傳活動廣泛傳播。
缺乏標準化的產品定義
這些食品的分類和監管因地區而異。這種不一致導致消費者和生產商感到困惑。產品類型缺乏科學共識,降低了產品的可信度。法律規範因地區而異,減緩了全球推廣。企業在標籤和行銷聲明方面面臨挑戰。儘管需求不斷成長,但這些因素限制了這些食品的廣泛應用。
功能性植物成分的整合
薑黃、生薑和綠茶等植物性成分正擴大被添加到食品和膳食補充劑中。創新的混合技術正在提升產品的營養價值和消費者興趣。價格親民、富含植物成分的產品能夠吸引廣泛的消費族群。與健康品牌合作可以進一步擴大市場覆蓋範圍。功能性植物性成分能夠在競爭激烈的市場中脫穎而出。預計這一機遇將推動產品多樣化的快速成長。
關於有效性的科學討論
一些專家質疑飲食療法在長期控制慢性疾病的有效性。矛盾的研究結果削弱了消費者的信心。監管機構要求提供可靠的證據來支持健康聲明。媒體對未經證實的療效的負面報道會阻礙產品的推廣。企業必須投入大量資金進行臨床試驗,以證明其產品的有效性。這場爭論是產品被大眾市場接受的一大障礙。
新冠疫情顯著提升了消費者對具有抗發炎功效食品的需求。疫情期間,消費者更重視增強免疫力和預防保健。機能性食品需求的成長推動了線上銷售管道的快速擴張。供應鏈中斷影響了原料的供應。經濟的不確定性限制了部分地區奢侈品的購買。人們對預防保健意識的提高促進了富含植物來源成分食品的流行。整體而言,疫情加速了長期需求的成長。
在預測期內,薑黃和薑黃素細分市場預計將是最大的。
在預測期內,薑黃和薑黃素預計將佔據最大的市場佔有率。這主要是因為消費者越來越傾向於將這些植物成分與抗發炎功效聯繫起來。薑黃類膳食補充劑和機能性食品透過零售和線上管道廣泛銷售。製造商正加大對口味創新的投入,以提高產品的市場接受度。在已開發市場,薑黃產品在零售市場正日益受到歡迎。注重預防保健的人傾向於選擇薑黃素進行日常健康維護。價格親民的產品也深受廣大消費者的青睞。
預計在預測期內,植物來源產品細分市場將呈現最高的複合年成長率。
在預測期內,由於消費者對永續和天然營養的需求不斷成長,植物來源產品細分市場預計將呈現最高的成長率。消費者出於健康和環保的雙重原因,開始植物來源抗發炎食品。尤其年輕一代,他們越來越傾向於富含植物的飲食。數位平台和健康宣傳活動正在普及植物來源食品的益處。零食、飲料和營養補充品的創新也進一步推動了植物性食品的流行。醫療保健專業人士也擴大推薦植物來源飲食來控制發炎。
在預測期內,由於植物來源產品日益受到認可,歐洲地區預計將佔據最大的市場佔有率。歐洲市場擁有完善的法規結構,為機能性食品的創新提供了支持。許多大型企業和研究機構的總部都設在該地區。消費者的永續發展意識已經逐漸形成。在德國、法國和英國等國家,抗發炎產品在零售市場越來越受歡迎。預防醫學和環保生活方式正在推動市場需求。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於人們健康意識的不斷提高。中國、印度和東南亞的都市區正迅速接受抗發炎食品。電子商務平台正在推動富含植物來源成分產品的分銷。文明病的日益增加正在提升人們對預防性營養的需求。價格親民的植物來源食品越來越受到一般消費者的歡迎。年輕一代也開始接受整體健康飲食。
According to Stratistics MRC, the Global Anti-Inflammatory Diet Products Market is accounted for $11.6 billion in 2026 and is expected to reach $24.8 billion by 2034 growing at a CAGR of 10% during the forecast period. Anti-inflammatory diet products are foods and beverages formulated with ingredients known to help reduce chronic inflammation and support overall wellness. These products often include omega-3 fatty acids, turmeric, ginger, berries, green tea extracts, antioxidants, and plant-based nutrients associated with anti-inflammatory properties. They are commonly targeted toward consumers seeking support for joint health, cardiovascular wellness, immune function, and healthy aging. Product formats include supplements, beverages, snacks, meal solutions, and fortified foods. Increasing awareness of inflammation's connection to chronic diseases is driving demand for nutrition-focused preventive health products globally.
Rising chronic disease prevalence
Consumers are becoming more aware of the role of inflammation in conditions such as arthritis, cardiovascular disease, and diabetes. Preventive health trends are encouraging adoption of anti-inflammatory foods and supplements. Healthcare providers are recommending dietary interventions to reduce inflammation. Food companies are innovating with functional ingredients to meet this demand. Social media and wellness campaigns are spreading knowledge about anti-inflammatory diets.
Limited standardized product definitions
Different regions classify and regulate these foods differently. This inconsistency creates confusion among consumers and manufacturers. Limited scientific consensus on product categories reduces credibility. Regulatory frameworks vary widely, slowing global expansion. Companies face challenges in labeling and marketing claims. This factor restricts wider adoption despite rising demand.
Functional botanical ingredient integration
Botanicals such as turmeric, ginger, and green tea are increasingly incorporated into foods and supplements. Innovation in blends enhances nutritional value and consumer appeal. Affordable botanical-rich options can attract mass-market buyers. Partnerships with wellness brands expand reach. Functional botanicals differentiate products in competitive markets. This opportunity is expected to drive rapid growth in product diversification.
Scientific debates over effectiveness
Some experts question the long-term impact of dietary interventions on chronic disease management. Conflicting studies reduce consumer confidence. Regulatory bodies demand strong evidence for health claims. Negative publicity around unverified benefits can slow adoption. Companies must invest heavily in clinical research to validate products. This debate creates barriers to mainstream acceptance.
Covid-19 significantly boosted demand for anti-inflammatory diet products. Consumers prioritized immunity and preventive health during the pandemic. Online sales channels grew rapidly as people sought functional foods. Supply chain disruptions affected ingredient availability. Economic uncertainty limited premium purchases in some regions. Preventive health awareness increased adoption of botanical-rich diets. Overall, the pandemic acted as a catalyst for long-term demand growth.
The turmeric & curcumin segment is expected to be the largest during the forecast period
The turmeric & curcumin segment is expected to account for the largest market share during the forecast period as consumers increasingly associate these botanicals with anti-inflammatory benefits. Turmeric-based supplements and functional foods are widely adopted across retail and online channels. Manufacturers are investing in flavor innovation to improve acceptance. Retail penetration of turmeric products is strong in developed markets. Preventive health seekers prefer curcumin for daily wellness routines. Affordable offerings appeal to mass consumers.
The plant-based products segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the plant-based products segment is predicted to witness the highest growth rate due to rising demand for sustainable and natural nutrition. Consumers are adopting plant-based anti-inflammatory foods for both health and environmental reasons. Younger demographics are particularly inclined toward plant-rich diets. Digital platforms and wellness campaigns promote plant-based benefits. Innovation in snacks, beverages, and supplements supports adoption. Healthcare providers are increasingly recommending plant-based diets for inflammation management.
During the forecast period, the Europe region is expected to hold the largest market share owing to established plant-based adoption. European markets have advanced regulatory frameworks supporting functional food innovation. Leading companies and research institutions are headquartered in this region. Sustainability trends are well established among consumers. Retail penetration of anti-inflammatory products is strong in countries such as Germany, France, and the UK. Preventive health and eco-conscious lifestyles drive demand.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by growing health consciousness. Urban populations in China, India, and Southeast Asia are adopting anti-inflammatory diets rapidly. E-commerce platforms support distribution of botanical-rich products. Lifestyle-related diseases are increasing, fueling demand for preventive nutrition. Affordable plant-based options appeal to mass consumers. Younger demographics are embracing holistic diets.
Key players in the market
Some of the key players in Anti-Inflammatory Diet Products Market include Nestle S.A., Danone S.A., PepsiCo, Inc., General Mills, Inc., Unilever plc, Abbott Laboratories, Herbalife Nutrition Ltd., Glanbia plc, Amway Corporation, The Hain Celestial Group, Inc., Simply Good Foods Company, Garden of Life LLC, Thorne HealthTech, Inc., Kerry Group plc and DSM-Firmenich.
In July 2025, PepsiCo announced the launch of Pepsi Prebiotic Cola, a functional version of its flagship soda containing 3g of fiber and only 30 calories. This product-led initiative, scheduled for a broad retail rollout in January 2026, targets the "gut-health-first" movement by offering a low-sugar, fiber-enriched option that supports a healthy inflammatory response without artificial sweeteners.
In March 2025, PepsiCo officially closed its $2 billion acquisition of the prebiotic soda brand Poppi to anchor its "Clean Label" wellness strategy. This strategic partnership-led move allows PepsiCo to dominate the functional, gut-health category by leveraging Poppi's cult following to attract younger, health-conscious consumers seeking anti-inflammatory alternatives to traditional sugary beverages.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.